Van der Eecken, H.; De Cock, D.; Roussel, E.; Giesen, A.; Vansevenant, B.; Goeman, L.; Quackels, T.; Joniau, S.
Nutritional Supplement with Fermented Soy in Patients Under Active Surveillance for Low-Risk or Intermediate-Risk Prostate Cancer: Results from the PRAEMUNE Trial. Cancers 2024, 16, 3634.
https://doi.org/10.3390/cancers16213634
AMA Style
Van der Eecken H, De Cock D, Roussel E, Giesen A, Vansevenant B, Goeman L, Quackels T, Joniau S.
Nutritional Supplement with Fermented Soy in Patients Under Active Surveillance for Low-Risk or Intermediate-Risk Prostate Cancer: Results from the PRAEMUNE Trial. Cancers. 2024; 16(21):3634.
https://doi.org/10.3390/cancers16213634
Chicago/Turabian Style
Van der Eecken, Hans, Diederik De Cock, Eduard Roussel, Alexander Giesen, Bram Vansevenant, Lieven Goeman, Thierry Quackels, and Steven Joniau.
2024. "Nutritional Supplement with Fermented Soy in Patients Under Active Surveillance for Low-Risk or Intermediate-Risk Prostate Cancer: Results from the PRAEMUNE Trial" Cancers 16, no. 21: 3634.
https://doi.org/10.3390/cancers16213634
APA Style
Van der Eecken, H., De Cock, D., Roussel, E., Giesen, A., Vansevenant, B., Goeman, L., Quackels, T., & Joniau, S.
(2024). Nutritional Supplement with Fermented Soy in Patients Under Active Surveillance for Low-Risk or Intermediate-Risk Prostate Cancer: Results from the PRAEMUNE Trial. Cancers, 16(21), 3634.
https://doi.org/10.3390/cancers16213634
